Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine for Cognitive Control in Late-life Depression
NCT04433767Phase 2Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Dec 2020
- Primary completion
- Oct 2022
- Countries
- 1
01
Overview
A Phase 2 trial of nicotine patch in major depressive disorder (MDD), sponsored by Vanderbilt University Medical Center. Started Dec 2020; status: completed.
02
Drugs
nicotine patch
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04433767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04433767.